Dr. Robert F. Reder is a seasoned pharmaceutical industry medical officer.  During his 30+ year career in the industry he has held operational and senior management level positions in Pharmacovigilance and Patient Safety, Clinical Development, and Medical Affairs involving multiple therapeutic areas.  His expertise includes addressing medical issues at each stage of the lifecycle of pharmaceutical products.

Dr. Reder practiced medicine as a US-trained and licensed physician for a number of years in New York City before joining the pharmaceutical industry in 1983. Since then, Dr. Reder has held full-time positions at Bristol-Myers Co., Knoll Pharmaceuticals, Sanofi Pharmaceuticals, Purdue Pharma LP, Endo Pharmaceuticals, Abbott Laboratories and AbbVie.

Dr. Reder is currently the Manager of BG Pharmaceutical Consulting LLC., based in the Chicago area.

---

Recent Presentations

• Reder RF, Ballal S, Steiner D, Landau C:  Evaluation of the Safety and Efficacy of Hydromorphone HCl Extended-Release and Fentanyl Transdermal System in Subjects with Persistent Moderate to Severe Nonmalignant Pain.  American Academy of Pain Medicine, 2006
• Scholten W, Reder R:  WHO:  Changing the Guidelines to Improve Patient Access to Controlled Medications.  IASP, 2008,Glasgow, Scotland
• Roman X, Barch D, Bano K, Reder R: An Approach to Aggregate Safety Reporting of Drug and Device Constituent Parts of Combination Products. DIA, Washington D.C., June 14-18, 2015.
• Reder RF, Naylor S, Bano K:  Safety Surveillance of Scientific Literature Related to Combination Products.  DIA, Ottawa, Canada, October 26-28, 2015.